Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program

NCT01198652 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2013-03-05

No results posted yet for this study

Summary

This is an open, post-marketing surveillance study obtaining data retrospectively on 300 women, of any age, treated with the BD-OTS for postpartum uterine bleeding.

Conditions

  • Postpartum Uterine Bleeding

Sponsors & Collaborators

  • Glenveigh Medical

    lead INDUSTRY

Principal Investigators

  • David Adair, MD · Glenveigh Medical

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01198652 on ClinicalTrials.gov